BodylogicalⓇ gives more power to consumers to do more with their health

Start adding items to your reading lists:
Sign in
or
Create your account
Save this item to:
This item has been saved to your reading list.

Overview

Too often, the effectiveness of fitness trackers drops off because there’s not enough insight and personal value in the information being collected, and; people often stick to doctor’s orders for a short amount of time and then slide back into their usual habits, often causing chronic conditions to worsen. 

How can we make managing health sticky? By putting the strength of Bodylogical’s prescriptive analytics directly into the hands of the individual health consumer. 

loading-player

Playback of this video is not currently available

Halt the progression of illness

Right now there’s no place a person can turn to get individualized answers about what his or her body requires to successfully alter the course of chronic conditions. For the first time, using Bodylogical, we can identify the unique requirements of each of our bodies in preventing and managing chronic conditions. Bodylogical makes it possible to pull the future closer to the present and identify outcomes and ROI before investing.

View more

Increase the success rate of new therapies

The predictive power of Bodylogical not only helps pharmaceutical and life sciences organizations increase the success rate for new therapies, it also helps shrink costs and accelerate timelines.

View more

Precision accelerates health

Every individual body responds differently to the many inter-related factors that can lead to chronic conditions or better health. Bodylogical makes it possible to simulate the unique requirements of our individual bodies when one or a confluence of multiple factors work together to affect our health.

View more

A 'digital twin' that models the human body and uses data to predict the health of 'future you'

Bodylogical will have major implications for the entire healthcare system - pharma, payers, providers and patients, and this study shows that it works. 

For pharmaceutical companies, it creates possibilities for faster, better targeted, and less expensive clinical trials, accelerating drugs to market and ultimately improving healthcare outcomes.

Payers and providers can use Bodylogical to see the future at an individual level guiding treatment of patients, and to better manage chronic diseases across patient populations.

loading-player

Playback of this video is not currently available

Results from PwC’s BodylogicalⓇ tool have been validated by a leading peer-reviewed scientific journal.

PwC Receives 2017 Google Cloud Partner Award for Data Analytics Customer Success

Bodylogical was recognized for this year’s award due to demonstrated expertise in Data Analytics Customer Success. Bodylogical empowers customers of any size in all industries to fuse analytics and science, create digital twins to help predict health/disease progression, determine appropriate lifestyle changes to improve health and, ultimately, help lower the overall cost of healthcare at all levels through a singularly unique product to achieve success in the cloud.

Read more

Download Precision accelerates health Bodylogical, new from PwC’s DoubleJump Health

Contact us

Kelly Barnes
US Health Industries and Global Health Industries Consulting Leader, PwC US
Tel: +1 (214) 754 5172
Email

Vaughn Kauffman
Principal, Health Industries, PwC US
Tel: +1 (440) 258 2729
Email

Jeff Gitlin
US Health Industries Advisory Leader, PwC US
Tel: +1 (860) 559 6511
Email

         

Follow us
Audit and assurance Consulting Tax services Newsroom Alumni US offices Contact us

© 2017 - 2018 PwC. All rights reserved. PwC refers to the US member firm or one of its subsidiaries or affiliates, and may sometimes refer to the PwC network. Each member firm is a separate legal entity. Please see www.pwc.com/structure for further details.